Editorial: It's time to make organized colorectal cancer screening convenient and easy for patients.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19293790.
- Also identified by DOI 10.1038/ajg.2009.18.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Colorectal cancer (CRC) screening is widely recommended, but underused. To increase screening rates, we need to implement organized and population-based systems to promote CRC screening among people in a single region, health plan, or health system. This is ideally accomplished using fecal immunochemical tests (FITs), which can be sent through a mass mailing. The study by Levi and colleagues shows that patients using aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), anti-platelet agents, or anti-coagulants do not need to stop these medications while doing the fecal collection. This makes the testing more convenient for patients, and avoids the risk of adverse cardiovascular events caused by stopping these medications.
Medical subject headings
- Colorectal Neoplasms
- Gastrointestinal Hemorrhage
- Mass Screening
- Occult Blood